NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England
Published date: 22 July 2021
Open opportunity – This means that the contract is currently active, and the buying department is looking for potential suppliers to fulfil the contract.
Watch this notice
Print this notice
Closing: 3 September 2021, 1pm
* Pharmaceutical products – 33600000
* Various medicinal products – 33690000
Location of contract
Value of contract
Previously, blood clot treatment was costing the NHS. 200 million a year.
Blood clots cost the NHS £570,000 a day
UK hospitals are treating 283 patients a day for blood clots costing the NHS almost £200 million a year, new research has revealed.
Exclusive figures obtained by RBR Active ahead of national Thrombosis Awareness Week show 34,515 people attended 69 hospital trusts between January 2018 and January 2019 suffering from deep vein thrombosis or pulmonary embolism at a cost of £66 million.
The statistics represent a third of the overall picture with 226 trusts in total approached under the Freedom of Information Act.
The National Institute for Health and Care Excellence (NICE) will develop a guideline on the management and treatment of rare blood clots and low platelet counts associated with COVID-19 vaccination.